Erica Mann has been a member of the Board of Management of Bayer AG and head of the Consumer Health Division, headquartered in Basel, Switzerland, since January 1, 2016.
Mann was born in Vereeniging, South Africa on October 11, 1958. She holds a degree in Analytical Chemistry and a Marketing Management Diploma from the Institute of Marketing Management in Johannesburg, South Africa.
She began her career in 1982 as a medical representative at Eli Lilly & Company in South Africa. This was followed by positions in Marketing at Johnson & Johnson and Lederle Laboratories. In 1992, she became head of the Lederle pharmaceutical business in South Africa before joining Wyeth as Managing Director for South Africa and Sub-Equatorial Africa in 1994. She then held positions of increasing responsibility at the company through 2009. In 2003, she was appointed Managing Director of Wyeth in Australia and New Zealand, where she introduced a range of significant medicines and nutritionals.
In April 2009, she became Senior Vice President for the global Nutrition business. Following the acquisition of Wyeth by Pfizer, Mann moved to the United States, where she was President and General Manager of Pfizer’s Nutrition Division and a member of the company’s Senior Management Team. In March 2011, she joined Bayer HealthCare as head of the Consumer Care Division and was appointed to the Bayer HealthCare Executive Committee at the same time.
Erica Mann has held executive positions in various industry organizations, including the South African Pharmaceutical Manufacturers’ Association (PMA), Medicines Australia and the International Association of Infant Food Manufacturers. She is the immediate past chair of the World Self Medication Industry Association, which represents the interests of the global nonprescription (over-the-counter, OTC) medicines industry.
Erica Mann has two adult children.